Oruka Therapeutics, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2020 | $3.9M | $50.4M | $49.1M |
| FY2021 | $3.9M | $54.9M | $53.4M |
| FY2022 | $1.4M | $43.1M | $42.4M |
| FY2023 | $841.0K | $37.9M | $37.4M |
| FY2024 | $13.8M | $1.0K | $61.6M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2020 | $3.9M | $50.4M | $49.1M |
| FY2021 | $3.9M | $54.9M | $53.4M |
| FY2022 | $1.4M | $43.1M | $42.4M |
| FY2023 | $841.0K | $37.9M | $37.4M |
| FY2024 | $13.8M | $1.0K | $61.6M |